Urbana, IL, United States of America

Emily Jane Geddes

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Emily Jane Geddes: Innovator in Antibiotic Development

Introduction

Emily Jane Geddes is a prominent inventor based in Urbana, IL (US). She has made significant contributions to the field of antibiotic research, particularly focusing on compounds effective against Gram-negative pathogens. With a total of two patents to her name, Geddes is recognized for her innovative approaches to combating microbial infections.

Latest Patents

Geddes' latest patents include groundbreaking work on Ribocil C antibiotics that are effective for Gram-negative pathogens. These patents disclose antibacterial compounds that accumulate in Gram-negative bacteria, along with methods for preparing and using these compounds to inhibit or kill microbes. The research emphasizes the strategic addition of amine substituents to selected compounds, enhancing their antibacterial activity against Gram-negative bacteria. This innovative approach aims to provide effective treatments for microbial infections, particularly those caused by Gram-negative bacteria.

Career Highlights

Emily Jane Geddes is affiliated with the University of Illinois, where she continues her research and development in antibiotic compounds. Her work has garnered attention for its potential impact on public health, especially in the fight against antibiotic-resistant bacteria. Geddes' dedication to her field is evident in her commitment to developing new and effective treatments.

Collaborations

Geddes collaborates with esteemed colleagues such as Paul Joseph Hergenrother and Bryon Shane Drown. These partnerships enhance her research efforts and contribute to the advancement of antibiotic development.

Conclusion

Emily Jane Geddes stands out as an influential inventor in the realm of antibiotic research. Her innovative patents and collaborative efforts reflect her commitment to addressing critical health challenges posed by Gram-negative pathogens. Her work continues to pave the way for new treatments and advancements in microbial infection management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…